Italy· 050111020
DIMETILFUMARATO GLENMARK
A dimethyl fumarate product containing dimetilfumarato, registered in Italy by GLENMARK PHARMACEUTICALS S.R.O, on the national reimbursement list. The same ATC class is registered in 13 of our 19 countries.
Checked against AIFA (Italy) on
Informational only — not a medical device.
Where it is registered
Dimethyl fumarate is registered in 13 of 19 countries.
Countries holding a registration under ATC L04AX07 (dimethyl fumarate), each read from that country’s own register.
- This record: Italy, from AIFA (Italy)
- 9 of them publish a price we can compare per daily dose
Dimethyl fumarate · ATC L04AX07
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of dimethyl fumarate costs, country by country.
Normalised to the WHO defined daily dose (0.48 g), so markets compare like for like.
- Italy: $20.95 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Dimethyl fumarate · price per daily dose (0.48 g)
USD · FX 28 Sept 2026
- IT Italy$20.95
- CH Switzerland$17.36
The record
At a glance
AIFA (Italy)- Active substance
- Dimetilfumarato
- Manufacturer
- GLENMARK PHARMACEUTICALS S.R.O
- Country
- Italy (IT)
- ATC code
- L04AX07
- ATC class
- Dimethyl fumarate
- Defined daily dose
- 0.48 g, O
- Reimbursed
- Yes
- Source register
- AIFA (Italy)
- Last checked
- September 28, 2026
Packs & prices · 1
1 priced- aic050111020"240 MG CAPSULE RIGIDE GASTRORESISTENTI" 56 CAPSULE IN BLISTER PVC/PVDC/ALEUR 515.21
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
317 interactions on record for dimethyl fumarate.
Graded by severity as the source publishes them — 32 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dimethyl fumarate · interactions on record
317 records
- 32 severe
- 285 moderate
Most severe, free to view
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- CladribineL01BB04severe
- PexidartinibL01EX15severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Dimethyl fumarate in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AIFA (Italy). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b2165fa6-51b8-4e12-8a82-1c46aad6f0c8 GET /v1/drugs/b2165fa6-51b8-4e12-8a82-1c46aad6f0c8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pack": "\"240 MG CAPSULE RIGIDE GASTRORESISTENTI\" 56 CAPSULE IN BLISTER PVC/PVDC/AL",
"source": "aifa",
"currency": "EUR",
"substance": "Dimetilfumarato",
"reference_pack": "56 UNITA' 240 MG - USO ORALE",
"public_price_eur": 515.21,
"ssn_reference_price_eur": 515.21
}See everything about dimethyl fumarate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.